MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
YU92202A
(sh)
|
2000-05-26 |
2006-01-16 |
Idenix (Cayman) Limited |
Metode i smeše za lečenje flavi virusa i pesti virusa
|
CN104193791A
(zh)
*
|
2002-06-28 |
2014-12-10 |
埃迪尼克斯医药公司 |
用于治疗黄病毒感染的修饰的2’和3’-核苷前药
|
WO2004009020A2
(fr)
|
2002-07-24 |
2004-01-29 |
Merck & Co., Inc. |
Derives de thionucleosides utilises comme inhibiteurs de l'arn-polymerase arn-dependante virale
|
CN1849142A
(zh)
|
2002-11-15 |
2006-10-18 |
埃迪尼克斯(开曼)有限公司 |
2′-支链核苷和黄病毒突变
|
EP3521297B1
(fr)
|
2003-05-30 |
2021-12-22 |
Gilead Pharmasset LLC |
Analogues de nucléoside fluorés modifiés
|
UA86962C2
(en)
|
2004-02-20 |
2009-06-10 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Viral polymerase inhibitors
|
CN101023094B
(zh)
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
ES2769377T3
(es)
|
2004-09-14 |
2020-06-25 |
Gilead Pharmasset Llc |
Intermedios de D-ribonolactona con sustitución de 2-fluoro-2-alquilo
|
EP1804811A4
(fr)
*
|
2004-09-24 |
2011-04-27 |
Idenix Cayman Ltd |
Methodes et compositions de traitement des flavivirus, des pestivirus et des hepacivirus
|
WO2007113159A1
(fr)
*
|
2006-04-04 |
2007-10-11 |
F. Hoffmann-La Roche Ag |
Nucléosides 3',5'-di-o-acylés destinés au traitement du vhc
|
BRPI0718714B8
(pt)
|
2006-11-09 |
2021-05-25 |
Hoffmann La Roche |
arilamidas substituídas por tiazol e oxazol, seu uso e composição farmacêutica que as compreende
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
US8933225B2
(en)
|
2007-08-02 |
2015-01-13 |
Millennium Pharmaceuticals, Inc. |
Process for the synthesis of E1 activating enzyme inhibitors
|
CN101903362B
(zh)
|
2007-12-17 |
2013-07-17 |
霍夫曼-拉罗奇有限公司 |
四唑取代的芳基酰胺衍生物和它们作为p2x3和/或p2x2/3嘌呤能受体拮抗物的用途
|
ES2570628T3
(es)
|
2007-12-17 |
2016-05-19 |
Hoffmann La Roche |
Nuevas arilamidas con sustitución imidazol
|
BR122018070508B8
(pt)
|
2007-12-17 |
2021-07-27 |
Hoffmann La Roche |
derivados de arilamida triazol-substituída e seu uso
|
EP2234976B1
(fr)
|
2007-12-17 |
2013-04-10 |
F. Hoffmann-La Roche AG |
Nouvelles arylamides substituées pyrazole
|
WO2010002428A2
(fr)
|
2008-06-06 |
2010-01-07 |
Scynexis, Inc. |
Nouveaux peptides macrocycliques
|
AU2009282567B2
(en)
*
|
2008-08-20 |
2014-10-02 |
Merck Sharp & Dohme Corp. |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
PA8855801A1
(es)
|
2008-12-23 |
2010-07-27 |
|
Sintesis de nucleosidos de purina
|
WO2010075517A2
(fr)
|
2008-12-23 |
2010-07-01 |
Pharmasset, Inc. |
Analogues de nucléoside
|
NZ593648A
(en)
|
2008-12-23 |
2013-09-27 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
EP2445897B1
(fr)
|
2009-06-22 |
2014-03-19 |
F.Hoffmann-La Roche Ag |
Nouveaux arylamides d'indazole comme antagonistes de p2x3 et/ou p2x2/3
|
ES2450891T3
(es)
|
2009-06-22 |
2014-03-25 |
F. Hoffmann-La Roche Ag |
Bifenilamidas útiles como moduladores de receptores P2X3 y/o P2X2/3
|
SG176640A1
(en)
|
2009-06-22 |
2012-01-30 |
Hoffmann La Roche |
Novel oxazolone and pyrrolidinone-substituted arylamides
|
KR20120104239A
(ko)
|
2009-11-14 |
2012-09-20 |
에프. 호프만-라 로슈 아게 |
Hcv 치료에 대한 신속한 반응을 예측하기 위한 바이오마커
|
WO2011067195A1
(fr)
|
2009-12-02 |
2011-06-09 |
F. Hoffmann-La Roche Ag |
Biomarqueurs pour prédire une réponse soutenue à un traitement du vhc
|
SI2609923T1
(sl)
|
2010-03-31 |
2017-10-30 |
Gilead Pharmasset Llc |
Postopek za kristalizacijo (s)-izopropil 2-(((s)-(perfluorofenoksi) (fenoksi)fosforil)amino)propanoata
|
ES2551944T3
(es)
|
2010-03-31 |
2015-11-24 |
Gilead Pharmasset Llc |
(S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihidropirimidin-1-(2H)-il)-4-fluoro-3-hidroxi-4-metiltetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato de isopropilo cristalino
|
WO2011123586A1
(fr)
|
2010-04-01 |
2011-10-06 |
Idenix Pharmaceuticals, Inc. |
Composés et compositions pharmaceutiques pour le traitement d'infections virales
|
JP6069215B2
(ja)
|
2010-11-30 |
2017-02-01 |
ギリアド ファーマセット エルエルシー |
化合物
|
CN103842369A
(zh)
|
2011-03-31 |
2014-06-04 |
埃迪尼克斯医药公司 |
用于治疗病毒感染的化合物和药物组合物
|
TW201329096A
(zh)
|
2011-09-12 |
2013-07-16 |
Idenix Pharmaceuticals Inc |
經取代羰氧基甲基磷酸醯胺化合物及用於治療病毒感染之藥學組成物
|
DE202012013074U1
(de)
|
2011-09-16 |
2014-10-29 |
Gilead Pharmasset Lcc |
Zusammensetzungen zur Behandlung von HCV
|
EP2768838A1
(fr)
|
2011-10-14 |
2014-08-27 |
IDENIX Pharmaceuticals, Inc. |
Phosphates 3',5'-cycliques substitués de composés nucléotidiques purines et compositions pharmaceutiques pour le traitement d'infections virales
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
NZ702744A
(en)
|
2012-05-22 |
2016-12-23 |
Idenix Pharmaceuticals Llc |
D-amino acid compounds for liver disease
|
WO2013177195A1
(fr)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
Promédicaments de 3',5'-phosphate cyclique pour traiter une infection par le virus de l'hépatite c
|
WO2013177188A1
(fr)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
Promédicaments de 3',5'-phosphoramidate cyclique pour traiter une infection par le virus de l'hépatite c
|
WO2013174962A1
(fr)
|
2012-05-25 |
2013-11-28 |
Janssen R&D Ireland |
Nucléosides d'uracyl spirooxétane
|
EP2900682A1
(fr)
|
2012-09-27 |
2015-08-05 |
IDENIX Pharmaceuticals, Inc. |
Esters et malonates de promédicaments à base de s-acyl-2-thioéthyle (sate)
|
KR102001280B1
(ko)
|
2012-10-08 |
2019-07-17 |
아이데닉스 파마슈티칼스 엘엘씨 |
Hcv 감염에 대한 2'-클로로 뉴클레오시드 유사체
|
US10723754B2
(en)
|
2012-10-22 |
2020-07-28 |
Idenix Pharmaceuticals Llc |
2′,4′-bridged nucleosides for HCV infection
|
US9211300B2
(en)
|
2012-12-19 |
2015-12-15 |
Idenix Pharmaceuticals Llc |
4′-fluoro nucleosides for the treatment of HCV
|
CN104144682A
(zh)
|
2013-01-31 |
2014-11-12 |
吉利德法莫赛特有限责任公司 |
两个抗病毒化合物的联用制剂
|
US9339541B2
(en)
|
2013-03-04 |
2016-05-17 |
Merck Sharp & Dohme Corp. |
Thiophosphate nucleosides for the treatment of HCV
|
US9309275B2
(en)
|
2013-03-04 |
2016-04-12 |
Idenix Pharmaceuticals Llc |
3′-deoxy nucleosides for the treatment of HCV
|
WO2014160484A1
(fr)
|
2013-03-13 |
2014-10-02 |
Idenix Pharmaceuticals, Inc. |
Pronucléotides de phosphoramidate d'acide aminé de 2'-cyano, azido et amino nucléosides pour le traitement du virus de l'hépatite c (vhc)
|
RU2534613C2
(ru)
|
2013-03-22 |
2014-11-27 |
Александр Васильевич Иващенко |
Алкил 2-{ [(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)- -гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино} -пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения
|
US9187515B2
(en)
|
2013-04-01 |
2015-11-17 |
Idenix Pharmaceuticals Llc |
2′,4′-fluoro nucleosides for the treatment of HCV
|
CN104151360B
(zh)
*
|
2013-05-14 |
2019-02-22 |
北京美倍他药物研究有限公司 |
磷酸/膦酸衍生物及其医药用途
|
US10005779B2
(en)
|
2013-06-05 |
2018-06-26 |
Idenix Pharmaceuticals Llc |
1′,4′-thio nucleosides for the treatment of HCV
|
WO2015017713A1
(fr)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
Pronucléotides phosphoramidates avec acides aminés d de composés halogéno pyrimidines pour le traitement des hépatopathies
|
ES2900570T3
(es)
|
2013-08-27 |
2022-03-17 |
Gilead Pharmasset Llc |
Formulación de combinación de dos compuestos antivirales
|
CN103524423B
(zh)
*
|
2013-09-18 |
2015-11-04 |
苏州乔纳森新材料科技有限公司 |
4,6-二氯代嘧啶-5-乙醛的制备方法
|
CN103554035B
(zh)
*
|
2013-10-29 |
2015-07-15 |
苏州乔纳森新材料科技有限公司 |
4,6-二卤代嘧啶-5-乙醛的制备方法
|
EP3131914B1
(fr)
|
2014-04-16 |
2023-05-10 |
Idenix Pharmaceuticals LLC |
Nucléosides méthyle ou alcynyle substitués en position 3 pour le traitement du virus de l'hépatite c
|
WO2016134057A1
(fr)
*
|
2015-02-18 |
2016-08-25 |
Abbvie Inc. |
Composés anti-viraux
|
WO2016134056A1
(fr)
*
|
2015-02-18 |
2016-08-25 |
Abbvie Inc. |
Composés anti-viraux
|
WO2016134051A1
(fr)
*
|
2015-02-18 |
2016-08-25 |
Abbvie Inc. |
Composés anti-viraux
|
WO2016134054A1
(fr)
*
|
2015-02-18 |
2016-08-25 |
Abbvie Inc. |
Composés anti-viraux
|
WO2017040766A1
(fr)
|
2015-09-02 |
2017-03-09 |
Abbvie Inc. |
Dérivés anti-viraux de tétrahydrofurane
|
CN109956975B
(zh)
*
|
2017-12-22 |
2020-11-06 |
浙江柏拉阿图医药科技有限公司 |
肝递送恩替卡韦前体药物核苷环磷酸酯化合物及应用
|
CN109761984B
(zh)
*
|
2019-02-27 |
2020-07-07 |
河南师范大学 |
不对称氢转移合成手性五元碳环嘌呤核苷的方法
|
CN112274516B
(zh)
*
|
2020-10-26 |
2022-08-05 |
中山大学附属第三医院 |
一种新型含碘抗病毒药物
|